Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2002
12/10/2002US6492129 Fragments comprising the n-terminal region of connective tissue growth factor (ctgf); screening for inhibitors or stimulators of ctgf
12/10/2002US6492126 Compositions and methods for the treatment and diagnosis of cardiovascular disease
12/10/2002US6492125 Method to assess library X library interactions
12/10/2002US6492123 Polypeptides comprising a first domain of an immunoglobulin heavy chain variable region, and a second domain of an immunoglobulin light chain variable region, linked but incapable of associating with each other; assay for antigen
12/10/2002US6492122 Determining concentration of preferential nucleotide sequences in sample; obtain nucleotide sequences, amplify, hybridize with amplicons, detect and quantitate hybridization products
12/10/2002US6492119 Film-shaped material, which is not apt to suffer from bending and creasing, is used as a base material, such that the macro array is easy to process
12/10/2002US6492118 Methods of immobilizing ligands on solid supports
12/10/2002US6492117 A cys2 his2 (cysteine2 histidine 2) zinc finger polypeptide that binds to a telomeric nucleic acid, a g-quadruplex nucleic acid, or a g-quartet nucleic acid; manipulating telomeres in vivo
12/10/2002US6492115 Genetic typing of the human cytochrome P450 2A6 gene and related materials and methods
12/10/2002US6492114 Generating nucleotide sequences from seed oil; extract nucleotide sequences from seed oil, mix with separation fluid, recover preferential nucleotide sequences
12/10/2002US6492112 Mitogen-activated protein kinase kinase 7 (MKK7)
12/10/2002US6492111 Oligonucleotides identiphores are caused to bind specifically to target nucleic acid which is predictive of a disease state such as cancer within cells, and are detected by spectrum analysis
12/10/2002US6492107 Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
12/10/2002US6492104 EIA test using nondenatured HIV antigen for early detection of HIV infection
12/10/2002US6491943 Method for treating an allergic or inflammatory disease
12/10/2002US6491926 35 kD tumor associated protein antigen: uses and methods of detection
12/10/2002US6491924 Sequence of at least 5 consecutive amino acids in the polypeptide of seq id no: 1
12/10/2002US6491920 Polypeptides and DNA encoding same
12/10/2002US6491915 Anti-CCR2 antibodies and methods of use therefor
12/10/2002US6491908 Selective elimination of T cells that recognize specific preselected targets
12/10/2002US6491907 Genetic engineered chimera particles comprising capsids from adeno-associated virus and genome inverted terminal repeat sequences as vectors for supplying and expressing nucleotide sequence in cells
12/10/2002US6491869 Method for preparing assay supports having an ordered set of reaction zones
12/10/2002US6491821 System and method for performing polynucleotide separations using liquid chromatography
12/10/2002CA2257118C Recombinant blood-coagulation proteases
12/10/2002CA2212150C Monoclonal antibodies for human osteogenic cell surface antigens
12/10/2002CA2196085C Mhc complexes and uses thereof
12/10/2002CA2114015C Recombinant antibodies for human therapy
12/10/2002CA2088574C Process for producing enzymes having superoxide dismutase activity, novel superoxide dismutase enzymes and novel pharmaceutical compositions comprising enzymes having superoxide dismutase activity
12/10/2002CA2085127C Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease
12/10/2002CA2080182C Nuclear inhibitor i-92 and its use for the production of a medicament
12/10/2002CA2077764C Antibody to pacap and use thereof
12/10/2002CA2047290C Recombinant marek's disease virus
12/09/2002WO2001096595A2 Method for the detection of influenza a/b viruses in saliva
12/08/2002WO2003000892A1 Gene encoding b protein
12/08/2002CA2398093A1 Gene encoding protein b
12/08/2002CA2365662A1 Transgenic rice plant and its family with environmental stress resistant by proline accumulation of high level and its production
12/05/2002WO2002097433A1 Use of duckweed in high throughput screening
12/05/2002WO2002097395A2 P-cadherin as a target for anti-cancer therapy
12/05/2002WO2002097390A2 A quantitative hybridization assay for the analysis of nucleic acid
12/05/2002WO2002097137A1 Light controlled gene expression utilizing heterologous phytochromes
12/05/2002WO2002097135A1 Accurate and efficient quantification of dna sensitivity by real-time pcr
12/05/2002WO2002097133A1 Antisense modulation of phospholipase a2, group iia (synovial) expression
12/05/2002WO2002097132A2 Nucleic acid detection method
12/05/2002WO2002097130A2 Microstructures and use thereof for the directed evolution of biomolecules
12/05/2002WO2002097126A2 Method for detecting gram-positive bacteria having a high gc content
12/05/2002WO2002097125A2 Tools for the diagnosis, molecular definition and development of treatment of chronic inflammatory joint diseases
12/05/2002WO2002097124A1 Pharmacological applications of mitochondrial dna assays
12/05/2002WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002WO2002097116A2 Delivery system for nucleic acids
12/05/2002WO2002097114A2 Nucleic acid treatment of diseases or conditions related to levels of ras, her2 and hiv
12/05/2002WO2002097110A2 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF
12/05/2002WO2002097108A2 Antisense modulation of dual specific phosphatase 5 expression
12/05/2002WO2002097104A1 Pseudotyping vih-1 vectors with the aid of rhabdovirus envelopes
12/05/2002WO2002097103A2 Constitutive plant promotor
12/05/2002WO2002097102A2 Modification of plant genomes by inducible site-specific recombination of trans genes
12/05/2002WO2002097101A1 Transgenic plants with reduced adenylate kinase activity showing an increased accumulation of starch
12/05/2002WO2002097100A2 Cloning vectors for homologous recombination and method using same
12/05/2002WO2002097099A1 Regulated expression of ghrh
12/05/2002WO2002097098A1 Vector for lactic acid bacteria and method for expressing ferritin in the lactic bacteria
12/05/2002WO2002097097A2 Compositions and methods of increasing stress tolerance in plants
12/05/2002WO2002097096A2 Nucleotide sequences which code for the metd gene
12/05/2002WO2002097095A1 Novel human transporter proteins and polynucleotides encoding the same
12/05/2002WO2002097094A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
12/05/2002WO2002097091A1 Generation of hcv-like particles and chimeric hcv virus
12/05/2002WO2002097087A1 Method of expressing foreign gene in kidney
12/05/2002WO2002097085A2 Callus specific plant promoters
12/05/2002WO2002097083A1 Method of extending long-chain dna
12/05/2002WO2002097082A2 Engineered biosynthesis of novel polyenes
12/05/2002WO2002097081A2 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production
12/05/2002WO2002097080A2 Amplification vectors based on trans-splicing
12/05/2002WO2002097079A2 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene
12/05/2002WO2002097078A1 Compositions and methods for random nucleic acid mutagenisis
12/05/2002WO2002097077A1 Method of preparing sucrose phosphorylase
12/05/2002WO2002097075A2 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
12/05/2002WO2002097065A2 Remodeling of somatic nuclei upon addition of pluripotent cell extracts
12/05/2002WO2002097063A1 Production of bioavailable folic acid
12/05/2002WO2002097062A2 Recombinant narbonolide polyketide synthase
12/05/2002WO2002097060A2 Carbohydrate-associated proteins
12/05/2002WO2002097059A2 Chromosome-based platforms
12/05/2002WO2002097056A2 Method for generating replication defective viral vectors that are helper free
12/05/2002WO2002097051A2 Protein arrays and methods and systems for producing the same
12/05/2002WO2002097050A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
12/05/2002WO2002097049A2 Compositions and methods for binding agglomeration proteins
12/05/2002WO2002097047A2 Compositions and methods for the inference of pigmentation traits
12/05/2002WO2002097046A2 B7 related protein-2 molecules and uses thereof
12/05/2002WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002WO2002097043A2 Wnv core protein/capsid interacting protein and uses of the same
12/05/2002WO2002097040A2 Methods for the identification of inhibitors of pectin esterase expression or activity in plants
12/05/2002WO2002097039A2 Novel human hydroxylases and polynucleotides encoding the same
12/05/2002WO2002097037A2 Melanin-concentrating hormone analogs
12/05/2002WO2002097035A2 Secreted proteins
12/05/2002WO2002097032A2 Proteins associated with cell growth, differentiation, and death
12/05/2002WO2002097031A2 Molecules for diagnostics and therapeutics
12/05/2002WO2002097030A2 Peptides derived from neural thread proteins and their medical use
12/05/2002WO2002096952A2 Conjugate of a transport protein and a protein for modulation of notch signalling
12/05/2002WO2002096951A1 Molecules for disease detection and treatment
12/05/2002WO2002096948A2 Engineered tetravalent antibodies and methods of use
12/05/2002WO2002096947A2 The lectin-like domain of thrombomodulin and its therapeutic use
12/05/2002WO2002096946A1 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy30
12/05/2002WO2002096944A2 New heterotetrameric potassium channels and uses thereof